BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 26724876)

  • 1. Immunohistochemical Expression of Calponin in Cutaneous Basal Cell Carcinoma.
    Bartoš V; Kullová M
    Acta Dermatovenerol Croat; 2015; 23(4):254-9. PubMed ID: 26724876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of P120catenin Expression in Human Basal Cell Carcinoma of the Skin.
    Bartoš V; Kullová M
    Acta Medica (Hradec Kralove); 2017; 60(1):32-36. PubMed ID: 28591550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of p16 Protein in Cutaneous Basal Cell Carcinoma: Still far from Being Clearly Understood.
    Bartoš V
    Acta Dermatovenerol Croat; 2020 Jul; 28(1):43-44. PubMed ID: 32650852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal cell carcinoma of the skin with mixed histomorphology: a comparative study.
    Bartoš V; Kullová M
    Cesk Patol; 2016; 52(4):222-226. PubMed ID: 27869450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. bcl-2 protein expression in aggressive and non-aggressive basal cell carcinomas.
    Ramdial PK; Madaree A; Reddy R; Chetty R
    J Cutan Pathol; 2000 Jul; 27(6):283-91. PubMed ID: 10885404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic basal cell carcinoma exhibits reduced actin expression.
    Uzquiano MC; Prieto VG; Nash JW; Ivan DS; Gong Y; Lazar AJ; Diwan AH
    Mod Pathol; 2008 May; 21(5):540-3. PubMed ID: 18223552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actin expression in purely nodular versus nodular-infiltrative basal cell carcinoma.
    Law AM; Oliveri CV; Pacheco-Quinto X; Horenstein MG
    J Cutan Pathol; 2003 Apr; 30(4):232-6. PubMed ID: 12680952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micronodular basal cell carcinoma: a distinct subtype? Relationship with nodular and infiltrative basal cell carcinomas.
    Betti R; Menni S; Radaelli G; Bombonato C; Crosti C
    J Dermatol; 2010 Jul; 37(7):611-6. PubMed ID: 20629826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of p53, D2-40 and α-smooth muscle actin in different histological subtypes of facial basal cell carcinoma.
    Mercut R; Ciurea ME; Mărgăritescu C; Popescu SM; Crăitoiu MM; Cotoi OS; Voinescu DC
    Rom J Morphol Embryol; 2014; 55(2):263-72. PubMed ID: 24969973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective study of 694 Basal Cell Carcinoma excisions to quantify deep margin documentation and clearance compared to histological type and surgical margin.
    Kiely JR; Patel AJK
    J Plast Reconstr Aesthet Surg; 2019 Nov; 72(11):1805-1812. PubMed ID: 31331722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
    Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
    Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal cell carcinoma progression correlates with host immune response and stromal alterations: a histologic analysis.
    Kaur P; Mulvaney M; Carlson JA
    Am J Dermatopathol; 2006 Aug; 28(4):293-307. PubMed ID: 16871032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial D310 D-Loop instability and histological subtypes in radiation-induced cutaneous basal cell carcinomas.
    Boaventura P; Pereira D; Mendes A; Batista R; da Silva AF; Guimarães I; Honavar M; Teixeira-Gomes J; Lopes JM; Máximo V; Soares P
    J Dermatol Sci; 2014 Jan; 73(1):31-9. PubMed ID: 24091058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duplicitous growth of infiltrative basal cell carcinoma: Analysis of clinically undetected tumor extent in a paired case-control study.
    Hendrix JD; Parlette HL
    Dermatol Surg; 1996 Jun; 22(6):535-9. PubMed ID: 8646468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha vbeta 6 Integrin promotes the invasion of morphoeic basal cell carcinoma through stromal modulation.
    Marsh D; Dickinson S; Neill GW; Marshall JF; Hart IR; Thomas GJ
    Cancer Res; 2008 May; 68(9):3295-303. PubMed ID: 18451156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoexpression of p53 and COX-2 in basal cell carcinoma.
    Enache AO; Stepan AE; Mărgăritescu C; Pătraşcu V; Ciurea RN; Simionescu CE; Camen A
    Rom J Morphol Embryol; 2018; 59(4):1115-1120. PubMed ID: 30845292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical nuclear staining for p53, PCNA, and Ki-67 in different histologic variants of basal cell carcinoma.
    Barrett TL; Smith KJ; Hodge JJ; Butler R; Hall FW; Skelton HG
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):430-7. PubMed ID: 9308559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desmoplastic Trichoepithelioma: An Uncommon but Diagnostically Problematic Benign Adnexal Tumor.
    Bartoš V
    Acta Dermatovenerol Croat; 2019 Dec; 27(4):282-284. PubMed ID: 31969246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of p53 in aggressive and non-aggressive histologic variants of basal cell carcinoma.
    Ansarin H; Daliri M; Soltani-Arabshahi R
    Eur J Dermatol; 2006; 16(5):543-7. PubMed ID: 17101476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased immunoreactivity of membrane type-1 matrix metalloproteinase (MT1-MMP) and β-catenin in high-risk basal cell carcinoma.
    Oh ST; Kim HS; Yoo NJ; Lee WS; Cho BK; Reichrath J
    Br J Dermatol; 2011 Dec; 165(6):1197-204. PubMed ID: 21729023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.